1:00 PM - 2:00 PM
Senior Product Manager Interview
Sarah Jenkins
Location
onsite, Jeddah, 02, Saudi Arabia
Commitment
Full Time
Level
Middle (2-4 years)
GSK Saudi Arabia is committed to supporting Vision 2030 and the Saudi Arabian National Agenda including Saudization in line with the hiring and the training and development of Saudi National capability.
GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patients globally. Our Ahead Together strategy is centred on early intervention to prevent and alter the course of disease, thereby protecting people and supporting healthcare systems.
Our diverse portfolio consists of vaccines, specialty medicines, and general medicines. Through continuous innovation and a dedicated focus on scientific and technical excellence, we strive to develop and launch new, groundbreaking treatments that address critical health challenges.
As a Marketing Manager & Launch Lead, you will play a pivotal role in driving the successful launch and lifecycle management of the assigned therapy area and brands. You will lead cross-functional teams, develop strategic marketing plans, and ensure alignment with GSK policies to deliver exceptional value to patients and healthcare providers.
This is an individual contributor role with no direct reports.
We are looking for professionals with these required skills to achieve our goals:
If you have the following characteristics, it would be a plus:
Please take a copy of the Job Description, as this will not be available post closure of the advert.
Data to Insights, Digital Fluency, Marketing Campaign Planning, Marketing Measurement, Marketing Strategy Implementation, Omnichannel Marketing, Scientific Literacy
Uniting science, technology and talent to get ahead of disease together. GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale. People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.